Ra Medical is looking to raise $15 million, having already raised $650,000 in a new round of equity financing, according to an SEC filing posted this week.
Funds already raised in the round came from 3 anonymous investors, with the 1st sale noted on September 5, according to the filing.
The company has not yet said how it plans to spend money in the round.
Ra Medical is aiming for a Feb. 2018 initial public offering, CEO Dean Irwin told MassDevice.com, after having received a nod from the FDA for its Dabra arteriosclerosis laser in May, clearing it for use in the US.